Looking At AstraZeneca's Recent Unusual Options Activity-March 2024-www.financetom.com

Looking At AstraZeneca's Recent Unusual Options Activity

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Looking At AstraZeneca's Recent Unusual Options Activity

Apr 19, 2024 2:29 PM

Financial giants have made a conspicuous bearish move on AstraZeneca ( AZN ). Our analysis of options history for AstraZeneca ( AZN ) revealed 12 unusual trades.

Delving into the details, we found 16% of traders were bullish, while 83% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $90,336, and 9 were calls, valued at $981,928.

What's The Price Target?

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $66.0 and $77.5 for AstraZeneca ( AZN ), spanning the last three months.

Insights into Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for AstraZeneca's ( AZN ) options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AstraZeneca's ( AZN ) whale activity within a strike price range from $66.0 to $77.5 in the last 30 days.

AstraZeneca Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
AZN	CALL	TRADE	BEARISH	04/19/24	$1.06	$0.9	$0.9	$67.50	$594.6K	14.1K	8.2K
AZN	CALL	SWEEP	BEARISH	04/19/24	$1.65	$1.54	$1.55	$67.00	$69.4K	2.5K	2.3K
AZN	CALL	SWEEP	BEARISH	04/19/24	$1.52	$1.51	$1.51	$67.00	$67.6K	2.5K	1.0K
AZN	CALL	SWEEP	BULLISH	04/19/24	$1.49	$1.25	$1.49	$67.00	$66.7K	2.5K	24
AZN	CALL	SWEEP	BEARISH	04/19/24	$1.57	$1.48	$1.49	$67.00	$49.6K	2.5K	920

About AstraZeneca

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca ( AZN ) in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

Following our analysis of the options activities associated with AstraZeneca ( AZN ), we pivot to a closer look at the company's own performance.

Where Is AstraZeneca Standing Right Now?

With a trading volume of 4,720,283, the price of AZN is up by 0.28%, reaching $68.55.

Current RSI values indicate that the stock is may be approaching overbought.

Next earnings report is scheduled for 6 days from now.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AstraZeneca ( AZN ) options trades with real-time alerts from Benzinga Pro.

Previous page： Atlassian Insider Sold Shares Worth $1,260,918, According to a Recent SEC Filing Next page： As Trump-Xi trade talks near, investors turn to history as a guide

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Atlassian Insider Sold Shares Worth $1,260,918, According to a Recent SEC Filing

Oct 28, 2025

03:38 AM EDT, 10/28/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on October 24, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,260,918. Following the Form 4 filing with the SEC, Farquhar has control over a total of 352,590 Class A common shares of the company, with 352,590 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612125000054/xslF345X05/primarydocument.xml ...

As Trump-Xi trade talks near, investors turn to history as a guide

Oct 28, 2025

NEW YORK/LONDON (Reuters) -Investors are heading into this week's trade talks between the U.S. and Chinese leaders with a sense of deja vu, excited by the proclamations of a truce and apprehensive the real deal may offer far less to celebrate. Stock markets across the world jumped on Monday after U.S. officials said negotiators from both sides had hashed out...

Atlassian Insider Sold Shares Worth $1,260,917, According to a Recent SEC Filing

Oct 28, 2025

03:38 AM EDT, 10/28/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on October 24, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,260,917. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 352,590 Class A common shares of the company, with 352,590 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000166612025000052/xslF345X05/primarydocument.xml...

SK Group chairman says rapid growth for AI data centres creating bottlenecks

Oct 28, 2025

By Ju-min Park GYEONGJU, South Korea, (Reuters) -The explosive growth in artificial intelligence data centres is creating bottlenecks for chips and other key supplies, SK Group Chairman Chey Tae-won said on Tuesday. I believe these rapid developments and changes are ultimately leading to bottlenecks around the world, said Chey, who heads the large South Korean conglomerate that includes memory chipmaker...